瘤透淋巴细胞治疗黑色素瘤和其他固体瘤:回顾过去,但仍向前迈进
Alexander N Shoushtari1, Daniel J Powell2
1Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.
Transplantation and cellular therapy
|March 15, 2025
概括
Lifileucel是一种新的采用性瘤透淋巴细胞 (TIL) 疗法,是首个批准用于固体瘤的细胞疗法,特别是晚期黑色素瘤. 这一突破为改善固体瘤治疗患者治疗结果提供了新的希望.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
背景情况:
- Lifileucel标志着一个重要的里程碑,因为它是第一个被批准的采用瘤透淋巴细胞 (TIL) 治疗固体瘤的治疗方法.
- 它在晚期黑色素瘤的批准意味着癌症治疗的细胞疗法取得了重大进展.
研究的目的:
- 审查在黑色素瘤中采用TIL治疗的历史发展.
- 为了突出TIL治疗其他固体瘤的最新进展.
- 预见TIL治疗的临床前和临床研究的未来方向.
主要方法:
- 关于采用TIL治疗的历史和最近研究的文献综述.
- 分析临床试验数据和监管批准流程.
- 探索正在进行的和未来的TIL治疗研究.
主要成果:
- 对Lifileucel在晚期黑色素瘤的监管批准是一个重大成就.
- 在其他固体瘤类型中,TIL疗法已经显示出超越黑色素瘤的前景.
- 目前正在进行的研究旨在提高TIL疗法的疗效和适用性.
结论:
- 采用TIL疗法,以Lifileucel为例,是治疗固体瘤的一种变革性方法.
- 持续的研究和开发对于为更广泛的患者群体优化TIL治疗至关重要.
- 黑色素瘤的成功为TIL治疗在瘤学中的扩大应用铺平了道路.
相关概念视频
01:27Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K